EU Agency backs respiratory drugs for approval

[riky]

EU Agency backs respiratory drugs for approval

European regulators recommended the approval of a clutch of drugs to treat respiratory diseases on Friday, including two from GlaxoSmithKline and another from Teva Pharmaceuticals. The European Medicines Agency (EMA) said four of the drugs recommended for approval were intended to treat the symptoms of chronic obstructive pulmonary disease (COPD), a condition that typically affects smokers, while another two were for asthma and COPD. Israeli drugmaker Teva received the nod for a combination of budesonide and formoterol, delivered by its Spiromax multi-dose dry powder inhaler, for the regular treatment of asthma and for the symptomatic treatment of patients with severe COPD.

Source: You are not allowed to view links. Register or Login